All Stories

  1. The Role of Folic Acid in DNA Methylation and Breast Cancer
  2. Metformin in combination with chemotherapy increases apoptosis in gastric cancer cells and counteracts senescence induced by chemotherapy
  3. Single nucleotide polymorphism rs4961 in the adducin 1 gene is not associated with gastric cancer or preneoplastic cancer lesions
  4. Pepsinogen I, pepsinogen II, gastrin-17, and Helicobacter pylori serological biomarkers in the diagnosis of precursor lesions of gastric cancer
  5. Medium and large alleles of the PGC gene are risk factors for gastric cancer
  6. Low expression of E-Cadherin and <i>Cdh1</i> variants associated with diffuse gastric cancer
  7. SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk
  8. Role of the BMP6 protein in breast cancer and other types of cancer
  9. Predicting Pathogenicity of CDH1 Gene Variants in Patients with Early-onset Diffuse Gastric Cancer from Western Mexico
  10. Molecular and Hematological Analysis of Alpha- and Beta-Thalassemia in a Cohort of Mexican Patients
  11. The Relationship of Single Nucleotide Polymorphisms in the TRPV1 Gene with Lipid Profile, Glucose, and Blood Pressure in Mexican Population
  12. LDLR Gene Mutation p.Asp360His and Familial Hypercholesterolemia in a Mexican Community
  13. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer
  14. Association of polymorphisms of the TNFRSF11B and TNFSF11 genes with bone mineral density in postmenopausal women from western Mexico
  15. The ERBB2 gene polymorphisms rs2643194, rs2934971, and rs1058808 are associated with increased risk of gastric cancer
  16. TYMS 2R3R polymorphism and DPYD [IVS]14+1G>A mutation genes in Mexican colorectal cancer patients
  17. Screening of LDLR and APOB gene mutations in Mexican patients with homozygous familial hypercholesterolemia
  18. Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer
  19. Los receptores epidérmicos humanos en el cáncer gástrico: alteraciones moleculares y su papel como diana terapéutica
  20. Three novel HBB mutations, c.-140C>G (-90 C>G), c.237_256delGGACAACCTCAAGGGCACCT (FS Cd 78/85 -20 bp), and c.315+2T>G (IVS2:2 T>G). Update of the mutational spectrum of β-Thalassemia in Mexican mestizo patients
  21. A Novel 31.1 kb α-Thalassemia Deletion (– –MEX3) Found in a Mexican Family
  22. Molecular analysis of complex cases of alpha- and beta-thalassemia in Mexican mestizo patients with microcytosis and hypochromia reveals two novel alpha0-thalassemia deletions - -Mex1and - -Mex2
  23. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population
  24. Epidermal growth factor receptor expression in gastric tumors and its relationship with the germline polymorphisms − 216 G>T, −191 C>A, (CA) n IVS1, and R521K
  25. 5′ and 3′ β-globin haplotypes in purepechas and Tarahumaras, two Mexican indigenous groups
  26. EGFR gene polymorphisms -216G>T and -191C>A are risk markers for gastric cancer in Mexican population
  27. Factores de riesgo para osteoporosis en mujeres posmenopáusicas de Guadalajara, Jalisco
  28. Association analysis of vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Mexican-Mestizo women
  29. Characterization of the 5′ and 3′ Breakpoints of the Spanish (δβ)0-Thalassemia Deletion in Mexican Patients
  30. Analysis of the SLC4A1 gene in three Mexican patients with hereditary spherocytosis: report of a novel mutation
  31. HB Fannin-Lubbock-I with A Single GGC>GAC Mutation at β119(GH2)Gly→Asp in a Homozygous Mexican Patient
  32. Molecular spectrum of β-thalassemia in the Mexican population
  33. Red cell membrane protein deficiencies in Mexican patients with hereditary spherocytosis
  34. Analysis of βS and βA Genes in a Mexican Population with African Roots